A Population-Based Study of Bacterial Spectrum in Febrile Neutropenic Patients

Background: Because of great concerns about mortality and morbidity of infection in febrile neutropenic patients, the appropriate empirical antibiotic should be started immediately. Although there are established guidelines for the use of empirical therapy, local microbiological pattern and antibiotic susceptibility should be considered. Objectives: The current study aimed to identify the etiological pathogens in febrile neutropenic cancer patients in Isfahan, Iran. Patients and Methods: This single-centre population-based study was conducted on 81 febrile neutropenic patients referring to Sayed-Al- Shohada hospital, the only referral malignant care center in Isfahan, Iran. Demographic data, duration and kind of malignancy, duration from last chemotherapy, duration of fever, and also physical exam were recorded for each patient. Moreover, procalcitonin, CRP, ESR, white blood cells, hemoglobin, platelet, and absolute neutrophil count were measured. BACTEC and E-test were used for blood culturing and determining the antibiotic susceptibility. Results: Out of 81 participants, 28.4% had positive blood cultures which mostly consisted of Gram-positive microorganisms. In addition, Staphylococcus epidermidis was the most isolated Gram positive bacteria (39.1%). ESR, CRP, and procalcitonin were significantly higher in patients with positive blood culture. The risk of infection increased with raise in duration of hospital stay, catheterization, increased pulse rate, increased oral temperature, low level of oxygen saturation, decreased systolic blood pressure, and low absolute neutrophile count. However, in this case, no relationship was found among the patients’ age, diastolic blood pressure, respiratory rate, duration of diagnosis, duration from last chemotherapy, duration of fever, white blood cells, hemoglobin, platelet, and finally the type of malignancies. Conclusions: It was concluded that Gram-positive bacteria were more prevalent as a cause of infection in the patients with malignancy and the most common pathogen was S. epidermidis. Larger studies are needed to determine the bacterial susceptibility of this center.

[1]  M. Meidani,et al.  Blood Culture in Neutropenic Patients with Fever , 2012, International journal of preventive medicine.

[2]  S. Kim,et al.  Evidence-Based Guidelines for Empirical Therapy of Neutropenic Fever in Korea , 2011, The Korean journal of internal medicine.

[3]  K. Sepkowitz,et al.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. D. Camargo Brazilian experience with the medium-term multi-organ bioassay: scientific and regulatory developments. , 2010 .

[5]  Z. M. Yusoff,et al.  Fever/clinical signs and association with neutropenia in solid cancer patients--bacterial infection as the main cause. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[6]  H. Hafeez,et al.  Bacterial spectrum and susceptibility patterns of pathogens in adult febrile neutropenic patients: a comparison between two time periods. , 2009, Journal of Ayub Medical College, Abbottabad : JAMC.

[7]  M. Anwar,et al.  BACTERIAL PATHOGENS RESPONSIBLE FOR BLOOD STREAM INFECTION (BSI) AND PATTERN OF DRUG RESISTANCE IN A TERTIARY CARE HOSPITAL OF LAHORE , 2009 .

[8]  R. Feld Bloodstream infections in cancer patients with febrile neutropenia. , 2008, International journal of antimicrobial agents.

[9]  G. Rossi,et al.  Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. , 2008, The Journal of antimicrobial chemotherapy.

[10]  H. Lyall,et al.  HIV and mitochondrial toxicity in children. , 2007, The Journal of antimicrobial chemotherapy.

[11]  C. Viscoli,et al.  A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  M. Paesmans,et al.  Bacteraemia in febrile neutropenic cancer patients. , 2007, International journal of antimicrobial agents.

[13]  S. Kaya,et al.  Comparison of the BACTEC blood culture system versus conventional methods for culture of normally sterile body fluids , 2007, Advances in therapy.

[14]  S. Ritchie,et al.  High‐risk febrile neutropenia in Auckland 2003–2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen‐specific therapy , 2007, Internal medicine journal.

[15]  D. Dzierżanowska,et al.  [Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment]. , 2006, Wiadomosci lekarskie.

[16]  C. Viscoli,et al.  Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. D. Pabón,et al.  El cambio climático y la salud humana , 2005 .

[18]  E. Poveda,et al.  Efecto del suplemento de aceites vegetales sobre el perfil lipídico en ratas wistar. , 2005 .

[19]  Sanjib K. Sharma,et al.  Melioidosis imported into Nepal , 2005, Scandinavian journal of infectious diseases.

[20]  S. Harthug,et al.  A multi-centre prospective study of febrile neutropenia in Norway: Microbiological findings and antimicrobial susceptibility , 2005, Scandinavian journal of infectious diseases.

[21]  E. González-Barca,et al.  Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution , 1996, European Journal of Clinical Microbiology and Infectious Diseases.

[22]  Yee-Chun Chen,et al.  Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy. , 2004, Journal of the Formosan Medical Association = Taiwan yi zhi.

[23]  P. Breig,et al.  Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[24]  S. Chu,et al.  Molecular epidemiology and control of nosocomial methicillin-resistant Staphylococcus aureus infection in a teaching hospital. , 2004, Journal of the Formosan Medical Association = Taiwan yi zhi.

[25]  A. Mahmood,et al.  Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern. , 2004, Journal of Ayub Medical College, Abbottabad : JAMC.

[26]  R. Mohamed Malays J Pathol , 2003 .

[27]  R. Wenzel,et al.  Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  M. Björkholm,et al.  Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. , 2003, The hematology journal : the official journal of the European Haematology Association.

[29]  H. Groen,et al.  Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategies. , 2002, Critical reviews in oncology/hematology.

[30]  J. Billé Laboratory diagnosis of infections in febrile neutropenic or immunocompromised patients. , 2000, International journal of antimicrobial agents.

[31]  S. Zinner Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  E. Kaiserova,et al.  Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome. , 1998, Journal of chemotherapy.

[33]  M. Paesmans,et al.  A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies , 1997, British journal of haematology.

[34]  N. Thanaletchimy,et al.  Comparative study of a non-radiometric BACTEC system and a conventional blood culture system in a clinical microbiology laboratory. , 1995, The Malaysian journal of pathology.

[35]  A. Pappo,et al.  The changing epidemiology of bacteremia in neutropenic children with cancer. , 1995, The Pediatric infectious disease journal.

[36]  A. Brown,et al.  The changing epidemiology of infections at cancer hospitals. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  W Satterlee,et al.  Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. , 1971, The New England journal of medicine.